| THERAVANCE BIOPHARMA |
| China |
| Gesundheit |
| KYG8807B1068 / A1137V |
| 0TB (Frankfurt) / TBPH (NASDAQ) |
| FRA:0TB, ETR:0TB, 0TB:GR, NASDAQ:TBPH |
| - |
| https://www.theravance.co.. |
|
Theravance Biopharma Inc. is a biopharmaceutical company engaged in the discovery, development, and commercialization of innovative medicines to address unmet clinical needs. Specializing in respirato..
>Volltext.. |
| 782.77 Mio. EUR |
| 540.21 Mio. EUR |
| 67.99 Mio. EUR |
| -25.07 Mio. EUR |
| 24.84 Mio. EUR |
| 0.49 EUR |
| 37.75 Mio. EUR |
| 147.94 Mio. EUR |
| 206.28 Mio. EUR |
| 8.81 |
| 20.61% |
| - |
| - |
| - |
| - |
| - |
| THERAVANCE BIOPHARMA, THERAVANCE BIO |
| 03.03.26 |
|
||||
|
||||
|
||||
|
||||
|